Frontlight ResearchEarly access
Trial site
North Kansas City Hospital
- 5running trials
- 2closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer2 trials
- Coronary artery disease2 trials
- Heart failure2 trials
- Alzheimer disease1 trial
- Bladder cancer1 trial
- Endometrial cancer1 trial
- Familial hypercholesterolaemia1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Kidney cancer1 trial
- Liver and biliary tract cancer1 trial
- Lung cancer1 trial
- and 12 more
- Phase
- Phase 34 trials
- Phase 41 trial
- Status
- Active, not recruiting3 trials
- Completed2 trials
- Recruiting2 trials
- Lead sponsor
- Boehringer Ingelheim2 trials
- Amgen1 trial
- Eli Lilly and Company1 trial
- Freenome Holdings Inc.1 trial
- Novartis Pharmaceuticals1 trial
- and 1 more
Running trials
Recruiting
Active, not recruiting
EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer1 recruiting
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Heart failure1 recruiting
- Kidney cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lung cancer1 recruiting
- Melanoma1 recruiting
- Mesothelioma1 recruiting
- Multiple myeloma1 recruiting
- Neuroendocrine tumours1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
- Sarcoma1 recruiting
- Testicular cancer1 recruiting
- Thymoma and thymic carcinoma1 recruiting
- Thyroid cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026